Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.
about
Heterologous Expression and Delivery of Biologically Active Exendin-4 by Lactobacillus paracasei L14Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization.Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.Recombinant Lactococcus lactis expressing bioactive exendin-4 to promote insulin secretion and beta-cell proliferation in vitro.Surface display on lactic acid bacteria without genetic modification: strategies and applications.Recombinant Lactococcus lactis Expressing Haemagglutinin from a Polish Avian H5N1 Isolate and Its Immunological Effect in Preliminary Animal Trials.Lactobacillus casei BL23 Produces Microvesicles Carrying Proteins That Have Been Associated with Its Probiotic EffectNisin-induced expression of recombinant T cell epitopes of major Japanese cedar pollen allergens in Lactococcus lactis.Identification and functional analysis of potential prophage-derived recombinases for genome editing in Lactobacillus casei.Development of bicistronic expression system for the enhanced and reliable production of recombinant proteins in Leuconostoc citreum.Engineering Components of the S-Layer for Biotherapeutic ApplicationsLactic Acid Bacteria for Delivery of Endogenous or Engineered Therapeutic Molecules
P2860
Q28552845-4AEC89C3-E617-466E-8328-2B120E3D54E5Q33632705-17131A47-9EE2-4A64-8B95-775E2ED2F486Q33650357-44DDA1B6-2934-4873-859F-69EAFA0B151FQ38614829-82A86D2B-4D9B-4304-A11E-696A453EE4C5Q38959870-E7291C0E-32B6-403C-A0C1-649B73266AD8Q40283850-5CE3F8C8-B21B-4AA8-BF7F-6FF603DE0CA2Q41836210-C57F196E-1A95-4D22-9581-AC40ECA953CCQ47389298-93D52207-6B8B-41B7-A790-86D0D06BC8CFQ47395379-83C02851-F9A0-4207-887B-00D6DB72AF0AQ55266145-FCDD6F93-76C7-427D-8D7E-0CF162725353Q58586624-AC76B625-53AC-4EA5-9954-8088403E8EEDQ58801803-CF7676F0-4C5D-403F-8223-5155AE610483
P2860
Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.
@en
type
label
Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.
@en
prefLabel
Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.
@en
P2093
P2860
P1476
Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.
@en
P2093
Yongguang Zhang
Zeqian Gao
P2860
P2888
P304
P356
10.1007/S00253-016-7557-X
P407
P577
2016-05-07T00:00:00Z
P6179
1001211162